- Home
- ALLR vs LGHL Comparison
ALLR vs LGHL Comparison
Compare ALLR & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- LGHL
- Stock Information
- Founded
- ALLR 2004
- LGHL 2015
- Country
- ALLR United States
- LGHL Singapore
- Employees
- ALLR N/A
- LGHL N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- LGHL Investment Bankers/Brokers/Service
- Sector
- ALLR Health Care
- LGHL Finance
- Exchange
- ALLR Nasdaq
- LGHL Nasdaq
- Market Cap
- ALLR 4.7M
- LGHL 4.3M
- IPO Year
- ALLR N/A
- LGHL N/A
- Fundamental
- Price
- ALLR $1.05
- LGHL $0.16
- Analyst Decision
- ALLR
- LGHL
- Analyst Count
- ALLR 0
- LGHL 0
- Target Price
- ALLR N/A
- LGHL N/A
- AVG Volume (30 Days)
- ALLR 2.6M
- LGHL 5.4M
- Earning Date
- ALLR 03-07-2025
- LGHL 01-28-2025
- Dividend Yield
- ALLR N/A
- LGHL N/A
- EPS Growth
- ALLR N/A
- LGHL N/A
- EPS
- ALLR N/A
- LGHL N/A
- Revenue
- ALLR N/A
- LGHL $13,659,110.00
- Revenue This Year
- ALLR N/A
- LGHL N/A
- Revenue Next Year
- ALLR N/A
- LGHL N/A
- P/E Ratio
- ALLR N/A
- LGHL N/A
- Revenue Growth
- ALLR N/A
- LGHL 11.35
- 52 Week Low
- ALLR $0.90
- LGHL $0.13
- 52 Week High
- ALLR $288.00
- LGHL $1.55
- Technical
- Relative Strength Index (RSI)
- ALLR 47.15
- LGHL 44.11
- Support Level
- ALLR $0.96
- LGHL $0.14
- Resistance Level
- ALLR $1.72
- LGHL $0.17
- Average True Range (ATR)
- ALLR 0.17
- LGHL 0.03
- MACD
- ALLR 0.01
- LGHL -0.00
- Stochastic Oscillator
- ALLR 13.99
- LGHL 10.64
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.